- Home
- VOXR vs MASS Comparison
VOXR vs MASS Comparison
Compare VOXR & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOXR
- MASS
- Stock Information
- Founded
- VOXR 2014
- MASS 2012
- Country
- VOXR United States
- MASS United States
- Employees
- VOXR N/A
- MASS N/A
- Industry
- VOXR Precious Metals
- MASS Medical/Dental Instruments
- Sector
- VOXR Basic Materials
- MASS Health Care
- Exchange
- VOXR Nasdaq
- MASS Nasdaq
- Market Cap
- VOXR 292.3M
- MASS 235.8M
- IPO Year
- VOXR N/A
- MASS 2020
- Fundamental
- Price
- VOXR $4.32
- MASS $8.56
- Analyst Decision
- VOXR
- MASS Strong Buy
- Analyst Count
- VOXR 0
- MASS 3
- Target Price
- VOXR N/A
- MASS $8.00
- AVG Volume (30 Days)
- VOXR 836.3K
- MASS 402.2K
- Earning Date
- VOXR 11-05-2025
- MASS 11-11-2025
- Dividend Yield
- VOXR 1.15%
- MASS N/A
- EPS Growth
- VOXR N/A
- MASS N/A
- EPS
- VOXR N/A
- MASS N/A
- Revenue
- VOXR $10,771,473.00
- MASS $65,560,000.00
- Revenue This Year
- VOXR $46.18
- MASS N/A
- Revenue Next Year
- VOXR $86.32
- MASS $22.29
- P/E Ratio
- VOXR N/A
- MASS N/A
- Revenue Growth
- VOXR N/A
- MASS 37.93
- 52 Week Low
- VOXR $2.21
- MASS $1.81
- 52 Week High
- VOXR $4.76
- MASS $9.22
- Technical
- Relative Strength Index (RSI)
- VOXR 55.21
- MASS 58.66
- Support Level
- VOXR $4.36
- MASS $7.68
- Resistance Level
- VOXR $4.76
- MASS $9.18
- Average True Range (ATR)
- VOXR 0.24
- MASS 0.51
- MACD
- VOXR -0.00
- MASS -0.08
- Stochastic Oscillator
- VOXR 40.67
- MASS 58.77
About VOXR Vox Royalty Corp.
Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector. The company geographically operates Australia, Nigeria, USA, and Brazil.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.